Callan Family Office LLC Makes New $1.02 Million Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Posted by Defense World Staff on Jun 17th, 2023

Callan Family Office LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,927 shares of the healthcare conglomerate’s stock, valued at approximately $1,022,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. MFA Wealth Advisors LLC raised its stake in UnitedHealth Group by 4.8% in the third quarter. MFA Wealth Advisors LLC now owns 414 shares of the healthcare conglomerate’s stock worth $209,000 after buying an additional 19 shares in the last quarter. Formidable Asset Management LLC raised its stake in UnitedHealth Group by 1.5% in the third quarter. Formidable Asset Management LLC now owns 1,366 shares of the healthcare conglomerate’s stock worth $741,000 after buying an additional 20 shares in the last quarter. Signet Financial Management LLC raised its stake in UnitedHealth Group by 2.2% in the first quarter. Signet Financial Management LLC now owns 964 shares of the healthcare conglomerate’s stock worth $491,000 after buying an additional 21 shares in the last quarter. McElhenny Sheffield Capital Management LLC increased its stake in shares of UnitedHealth Group by 1.6% during the fourth quarter. McElhenny Sheffield Capital Management LLC now owns 1,317 shares of the healthcare conglomerate’s stock valued at $698,000 after purchasing an additional 21 shares in the last quarter. Finally, First Bank & Trust increased its stake in shares of UnitedHealth Group by 1.9% during the fourth quarter. First Bank & Trust now owns 1,115 shares of the healthcare conglomerate’s stock valued at $591,000 after purchasing an additional 21 shares in the last quarter. 86.31% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Andrew Witty sold 6,160 shares of UnitedHealth Group stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total value of $3,002,938.40. Following the completion of the transaction, the chief executive officer now directly owns 86,564 shares of the company’s stock, valued at approximately $42,199,084.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other UnitedHealth Group news, CEO Andrew Witty sold 6,160 shares of UnitedHealth Group stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total value of $3,002,938.40. Following the completion of the transaction, the chief executive officer now directly owns 86,564 shares of the company’s stock, valued at approximately $42,199,084.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,008 shares of UnitedHealth Group stock in a transaction dated Friday, April 21st. The stock was sold at an average price of $484.58, for a total transaction of $488,456.64. Following the transaction, the executive vice president now directly owns 10,359 shares of the company’s stock, valued at $5,019,764.22. The disclosure for this sale can be found here. Insiders sold 8,852 shares of company stock valued at $4,313,962 in the last three months. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Down 1.6 %

Shares of UNH stock opened at $458.39 on Friday. The company has a market capitalization of $426.77 billion, a price-to-earnings ratio of 20.96, a PEG ratio of 1.34 and a beta of 0.68. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $558.10. The company’s fifty day moving average price is $489.88 and its 200-day moving average price is $494.88. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.81 and a quick ratio of 0.81.

UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings data on Friday, April 14th. The healthcare conglomerate reported $6.26 EPS for the quarter, beating the consensus estimate of $6.24 by $0.02. The firm had revenue of $91.93 billion for the quarter, compared to the consensus estimate of $89.77 billion. UnitedHealth Group had a net margin of 6.16% and a return on equity of 27.05%. The company’s revenue was up 14.7% on a year-over-year basis. During the same period last year, the firm earned $5.49 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 24.9 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th will be paid a $1.88 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.65. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.64%. The ex-dividend date is Thursday, June 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 30.18%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on UNH shares. TD Cowen decreased their target price on shares of UnitedHealth Group from $596.00 to $562.00 and set an “outperform” rating for the company in a research note on Monday, April 17th. SVB Securities cut their price target on shares of UnitedHealth Group from $625.00 to $560.00 in a report on Wednesday. JPMorgan Chase & Co. cut their price target on shares of UnitedHealth Group from $595.00 to $562.00 in a report on Tuesday, May 30th. Cantor Fitzgerald started coverage on shares of UnitedHealth Group in a report on Thursday, April 20th. They set an “overweight” rating and a $591.00 price target on the stock. Finally, Truist Financial dropped their target price on shares of UnitedHealth Group from $610.00 to $580.00 in a report on Wednesday. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $592.68.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.